+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Particle Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4851369
  • Report
  • February 2019
  • Region: Global
  • 230 pages
  • Transparency Market Research
1 of 2

Particle Therapy Market - Overview

This report on the particle therapy market analyzes the current and future scenario of the global market. Large number of cancer patients opting for particle therapy and incidences of brain tumor occurrence among the geriatric population are boosting the usage of proton and carbon therapy. Less pain and high definition healing technology are major drivers of the global particle therapy market.

The particle therapy market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on services, therapy, cancer application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Additionally, the section comprises major player’s product portfolio-based on technology & cancer application to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global particle therapy market.

Based on therapy, the market has been segmented into proton therapy, carbon therapy, and other therapy. The therapy segment has been analyzed based on available centers providing particle therapy, cost-effectiveness, and preference for therapy by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Based on services, the market has been segmented into cyclotrons, synchrotrons, and synchrocyclotrons. The therapy segment has been analyzed based on available centers established with different services in different regions/country, cost-effectiveness, and preference for therapy by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Based on end-user, the particle therapy market has been classified into hospitals, specialty clinics, ambulatory surgical centers, and others. The particle therapy market has also been segmented based on the application of particle therapy for cancer treatment. The market segments have been extensively analyzed based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of region, the global particle therapy market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global particle therapy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Varian Medical Systems, Inc., Hitachi, Ltd., IBA Worldwide, Sumitomo Heavy Industries, Ltd., Advanced Oncotherapy PLC., Mevion Medical Systems, Inc., Provision Healthcare, LLC,  Optivus Proton Therapy, Inc., Protom International, Inc., and Danfysik A/S.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Particle Therapy Market

4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Particle Therapy Market Analysis and Forecast, 2016-2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Market Outlook
4.6. Regulatory Scenarios
4.7. Particle therapy facilities in clinical operation, 2017
4.8. Pricing Analysis, 2017

5. Global Particle Therapy Market Analysis and Forecast, by Therapy
5.1. Introduction & Definition
5.2. Key Findings/Developments
5.3. Global Particle Therapy Market Forecast, by Therapy, 2016-2026
5.3.1. Photon Therapy
5.3.2. Carbon Therapy
5.3.3. Other Therapy
5.4. Global Particle Therapy Market Attractiveness, by Therapy

6. Global Particle Therapy Market Analysis and Forecast, by Cancer Application
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Particle Therapy Market Forecast, by Cancer Application, 2016-2026
6.3.1. Pediatric Cancer
6.3.2. Lung Cancer
6.3.3. Bladder Cancer
6.3.4. Brain and Spinal Cord Tumors (BSCT)
6.3.5. Breast Cancer
6.3.6. Gastrointestinal (GI) Cancers
6.3.7. Hepatocellular Carcinoma (HCC)
6.3.8. Head and Neck Cancers (HNC)
6.3.9. Others
6.4. Global Particle Therapy Market Attractiveness, by Cancer Application

7. Global Particle Therapy Market Analysis and Forecast, by Services
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Particle Therapy Market Forecast, by Services, 2016-2026
7.3.1. Cyclotrons
7.3.2. Synchrotrons
7.3.3. Synchrocyclotrons
7.4. Global Particle Therapy Market Attractiveness, by Services

8. Global Particle Therapy Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Global Particle Therapy Market Forecast, by End-user, 2016-2026
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Ambulatory Surgical Centers
8.3.4. Others
8.4. Global Particle Therapy Market Attractiveness, by End-user

9. Global Particle Therapy Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Particle Therapy Market Attractiveness, by Region

10. North America Particle Therapy Market Analysis and Forecast
10.1.Introduction
10.1.1. Key Findings
10.2. North America Particle Therapy Market Forecast, by Therapy, 2016-2026
10.2.1. Photon Therapy
10.2.2. Carbon Therapy
10.2.3. Other Therapy
10.3. North America Particle Therapy Market Forecast, by Cancer Application, 2016-2026
10.3.1. Pediatric Cancer
10.3.2. Lung Cancer
10.3.3. Bladder Cancer
10.3.4. Brain and Spinal Cord Tumors (BSCT)
10.3.5. Breast Cancer
10.3.6. Gastrointestinal (GI) Cancers
10.3.7. Hepatocellular Carcinoma (HCC)
10.3.8. Head and Neck Cancers (HNC)
10.3.9. Others
10.4. North America Particle Therapy Market Forecast, by Services, 2016-2026
10.4.1. Cyclotrons
10.4.2. Synchrotrons
10.4.3. Synchrocyclotrons
10.5. North America Particle Therapy Market Forecast, by End-user, 2016-2026
10.5.1. Hospitals
10.5.2. Specialty Clinics
10.5.3. Ambulatory Surgical Centers
10.5.4. Others
10.6. North America Particle Therapy Market Forecast, by Country, 2016-2026
10.6.1. U.S.
10.6.2. Canada
10.7. North America Particle Therapy Market Attractiveness Analysis
10.7.1. By Therapy
10.7.2. By Cancer Application
10.7.3. By Services
10.7.4. By End-user
10.7.5. By Country

11. Europe Particle Therapy Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2. Europe Particle Therapy Market Forecast, by Therapy, 2016-2026
11.2.1. Photon Therapy
11.2.2. Carbon Therapy
11.2.3. Other Therapy
11.3. Europe Particle Therapy Market Forecast, by Cancer Application, 2016-2026
11.3.1. Pediatric Cancer
11.3.2. Lung Cancer
11.3.3. Bladder Cancer
11.3.4. Brain and Spinal Cord Tumors (BSCT)
11.3.5. Breast Cancer
11.3.6. Gastrointestinal (GI) Cancers
11.3.7. Hepatocellular Carcinoma (HCC)
11.3.8. Head and Neck Cancers (HNC)
11.3.9. Others
11.4. Europe Particle Therapy Market Forecast, by Services, 2016-2026
11.4.1. Cyclotrons
11.4.2. Synchrotrons
11.4.3. Synchrocyclotrons
11.5. Europe Particle Therapy Market Forecast, by End-user, 2016-2026
11.5.1. Hospitals
11.5.2. Specialty Clinics
11.5.3. Ambulatory Surgical Centers
11.5.4. Others
11.6. Europe Particle Therapy Market Forecast, by Country/Sub-region, 2016-2026
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Spain
11.6.5. Italy
11.6.6. Rest of Europe
11.7. Europe Particle Therapy Market Attractiveness Analysis
11.7.1. By Therapy
11.7.2. By Cancer Application
11.7.3. By Services
11.7.4. By End-user
11.7.5. By Country/Sub-region

12. Asia Pacific Particle Therapy Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2. Asia Pacific Particle Therapy Market Forecast, by Therapy, 2016-2026
12.2.1. Photon Therapy
12.2.2. Carbon Therapy
12.2.3. Other Therapy
12.3. Asia Pacific Particle Therapy Market Forecast, by Cancer Application, 2016-2026
12.3.1. Pediatric Cancer
12.3.2. Lung Cancer
12.3.3. Bladder Cancer
12.3.4. Brain and Spinal Cord Tumors (BSCT)
12.3.5. Breast Cancer
12.3.6. Gastrointestinal (GI) Cancers
12.3.7. Hepatocellular Carcinoma (HCC)
12.3.8. Head and Neck Cancers (HNC)
12.3.9. Others
12.4. Asia Pacific Particle Therapy Market Forecast, by Services, 2016-2026
12.4.1. Cyclotrons
12.4.2. Synchrotrons
12.4.3. Synchrocyclotrons
12.5. Asia Pacific Particle Therapy Market Forecast, by End-user, 2016-2026
12.5.1. Hospitals
12.5.2. Specialty Clinics
12.5.3. Ambulatory Surgical Centers
12.5.4. Others
12.6. Asia Pacific Particle Therapy Market Forecast, by Country/Sub-region, 2016-2026
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Asia Pacific Particle Therapy Market Attractiveness Analysis
12.7.1. By Therapy
12.7.2. By Cancer Application
12.7.3. By Services
12.7.4. By End-user
12.7.5. By Country/Sub-region

13. Latin America Particle Therapy Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2. Latin America Particle Therapy Market Forecast, by Therapy, 2016-2026
13.2.1. Photon Therapy
13.2.2. Carbon Therapy
13.2.3. Other Therapy
13.3. Latin America Particle Therapy Market Forecast, by Cancer Application, 2016-2026
13.3.1. Pediatric Cancer
13.3.2. Lung Cancer
13.3.3. Bladder Cancer
13.3.4. Brain and Spinal Cord Tumors (BSCT)
13.3.5. Breast Cancer
13.3.6. Gastrointestinal (GI) Cancers
13.3.7. Hepatocellular Carcinoma (HCC)
13.3.8. Head and Neck Cancers (HNC)
13.3.9. Others
13.4. Latin America Particle Therapy Market Forecast, by Services, 2016-2026
13.4.1. Cyclotrons
13.4.2. Synchrotrons
13.4.3. Synchrocyclotrons
13.5. Latin America Particle Therapy Market Forecast, by End-user, 2016-2026
13.5.1. Hospitals
13.5.2. Specialty Clinics
13.5.3. Ambulatory Surgical Centers
13.5.4. Others
13.6. Latin America Particle Therapy Market Forecast, by Country/Sub-region, 2016-2026
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Latin America Particle Therapy Market Attractiveness Analysis
13.7.1. By Therapy
13.7.2. By Cancer Application
13.7.3. By Services
13.7.4. By End-user
13.7.5. By Country/Sub-region

14. Middle East & Africa Particle Therapy Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Particle Therapy Market Forecast, by Therapy, 2016-2026
14.2.1. Photon Therapy
14.2.2. Carbon Therapy
14.2.3. Other Therapy
14.3. Middle East & Africa Particle Therapy Market Forecast, by Cancer Application, 2016-2026
14.3.1. Pediatric Cancer
14.3.2. Lung Cancer
14.3.3. Bladder Cancer
14.3.4. Brain and Spinal Cord Tumors (BSCT)
14.3.5. Breast Cancer
14.3.6. Gastrointestinal (GI) Cancers
14.3.7. Hepatocellular Carcinoma (HCC)
14.3.8. Head and Neck Cancers (HNC)
14.3.9. Others
14.4. Middle East & Africa Particle Therapy Market Forecast, by Services, 2016-2026
14.4.1. Cyclotrons
14.4.2. Synchrotrons
14.4.3. Synchrocyclotrons
14.5. Middle East & Africa Particle Therapy Market Forecast, by End-user, 2016-2026
14.5.1. Hospitals
14.5.2. Specialty Clinics
14.5.3. Ambulatory Surgical Centers
14.5.4. Others
14.6. Middle East & Africa Particle Therapy Market Forecast, by Country/Sub-region, 2016-2026
14.6.1. GCC countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Middle East & Africa Particle Therapy Market Attractiveness Analysis
14.7.1. By Therapy
14.7.2. By Cancer Application
14.7.3. By Services
14.7.4. By End-user
14.7.5. By Country/Sub-region

15. Competition Landscape
15.1.Market Player - Competition Matrix (By Tier and Size of companies)
15.2.Market Share Analysis By Company (2017)
15.3.Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
15.3.1. Varian Medical Systems, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Hitachi, Ltd.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. IBA Worldwide
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Advanced Oncotherapy PLC.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Mevion Medical Systems, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Danfysik A/S
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Sumitomo Heavy Industries, Ltd.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Optivus Proton Therapy, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Protom International, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Others
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll